Pazufloxacin mesylate

Overview

Pazufloxacin mesylate is an orally active fluoroquinolone antimicrobial agent. Pazufloxacin mesylate inhibits DNA gyrase with IC 50 values of 0.88 μg/mL ( E. coli ) and 1.9 μg/mL ( P. aeruginosa ). Pazufloxacin mesylate exhibits broad-spectrum antimicrobial activity, with MIC 90 values ranging from 0.025 to 100 μg/mL against Gram-positive and Gram-negative bacteria, non-fermenting bacteria, Legionella spp., and anaerobic bacteria. Pazufloxacin mesylate is indicated for research on systemic infections, lung infections, urinary tract infections, and Legionella pneumonia.

Application

Products | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Lung Fibrosis | Products > Disease Areas > Infection | Products > Disease Areas > Respiratory Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Pulmonary Disease | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Infection | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-B0724A
• CAS No.: 163680-77-1
• Molecular Formula: C17H19FN2O7S
• Molecular Weight: 414.41
• Purity: 99.97%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 2.5 mg/mL (6.03 mM); Clear solution
• Availability: In-stock

Source

Original product source